HBV-TAG Virtual 2021 Conference

The first 2021 Hepatitis B – Therapeutic Agents (HBV-TAG) Conference will be held virtually June 11-12, 2021. The conference will provide attendees with a unique opportunity to learn from leading researchers about the latest innovative science on HBV and engage in interactive discussions by sharing their insights with others on multiple topics related to advances in HBV therapeutic agent development and the diagnosis and management of patients with HBV.

Course Directors

• Robert Gish, MD, Clinical Professor of Medicine, Loma Linda University Medical Director, Hepatitis B Foundation
• Ira Jacobson, MD, Director of Hepatology, Professor of Medicine NYU Grossman School of Medicine

Register here: https://mfuhrer100.wufoo.com/forms/hbvtag-2021-virtual-conference-registration/